A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples